AI assistant
Sending…
Vanda Pharmaceuticals Inc. — Director's Dealing 2021
Mar 8, 2021
33390_dirs_2021-03-08_0d31b57c-9718-46fc-bf02-79ab859f395d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2021-03-05
Reporting Person: Williams Timothy (SVP & General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-05 | Common Stock | S | 200 | $17.88 | Disposed | 92326 | Direct |
| 2021-03-05 | Common Stock | S | 5400 | $17.85 | Disposed | 86926 | Direct |
More from Vanda Pharmaceuticals Inc.
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 23
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19